REVOLAX is a Hyaluronic Acid (HA) Dermal Filler, which was developed in South Korea in 2013. It obtained its KFDA approval in the same year and quickly became a staple in the Korean aesthetic industry after its release.
REVOLAX is known for being a premium product, sold at an affordable price. REVOLAX is thoroughly tested and undergoes several dialysis procedures to meet ISO standards To maintain the same high quality as its market-leading competitors. Fox Group International obtained the sole distribution rights for the UK and Germany and is staying true to its company guidelines: Quality, Affordability, and Happiness. By sourcing REVOLAX directly from the manufacturer in South Korea, Fox Group International are able to offer REVOLAX to yourself at the lowest possible price.
REVOLAX uses the latest dermal filler technology within its entire product line and offers three different products: REVOLAX Fine, REVOLAX Deep and REVOLAX Sub-Q.
Revolax filler is a non-animal based hyaluronic acid with a high purity that corrects facial wrinkles and sculptures the face lines. The products have a high visco-elasticity and its consistency creates immediate and long-lasting volume.
Revolax consists of a highly consistent monophasic structure. The regular and monophasic structure makes the gel a stable consistent. Furthermore, it has a low content of product migration, which means that once injected, the filler is more likely to stay close to the injection site and give an accurate result.
Revolax includes three product categories, Fine, Deep and Sub-Q are designed to treat each its specific area and need. The consistency of each product allows for natural volume, smooth injection and promotes a stronger support system within the skin structure. The products are designed in order to appear natural until it over time is absorbed into the skin.